Rize Oncology Inc. (CSE:RIZE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0300
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT

Rize Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Selling, General & Admin
0.560.551.181.230.01
Upgrade
Research & Development
0.030.20.530.40.06
Upgrade
Operating Expenses
0.590.751.721.640.07
Upgrade
Operating Income
-0.59-0.75-1.72-1.64-0.07
Upgrade
Interest Expense
----0-0
Upgrade
Interest & Investment Income
0.040.050--
Upgrade
Currency Exchange Gain (Loss)
00.01-0-0-
Upgrade
Pretax Income
-0.55-0.69-1.72-1.64-0.07
Upgrade
Net Income
-0.55-0.69-1.72-1.64-0.07
Upgrade
Net Income to Common
-0.55-0.69-1.72-1.64-0.07
Upgrade
Shares Outstanding (Basic)
3946433627
Upgrade
Shares Outstanding (Diluted)
3946433627
Upgrade
Shares Change (YoY)
-16.52%7.75%20.45%32.93%3729.11%
Upgrade
EPS (Basic)
-0.01-0.01-0.04-0.05-0.00
Upgrade
EPS (Diluted)
-0.01-0.01-0.04-0.05-0.00
Upgrade
EBIT
-0.59-0.75-1.72-1.64-0.07
Upgrade
Updated Nov 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.